These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 3731053

  • 1. Effect of methotrexate-monoclonal anti-prostatic acid phosphatase antibody conjugate on human prostate tumor.
    Deguchi T, Chu TM, Leong SS, Horoszewicz JS, Lee CL.
    Cancer Res; 1986 Aug; 46(8):3751-5. PubMed ID: 3731053
    [Abstract] [Full Text] [Related]

  • 2. Nature of linkage and mode of action of methotrexate conjugated with antitumor antibodies: implications for future preparation of conjugates.
    Endo N, Takeda Y, Umemoto N, Kishida K, Watanabe K, Saito M, Kato Y, Hara T.
    Cancer Res; 1988 Jun 15; 48(12):3330-5. PubMed ID: 3259466
    [Abstract] [Full Text] [Related]

  • 3. Targeting, internalization, and cytotoxicity of methotrexate-monoclonal anti-stage-specific embryonic antigen-1 antibody conjugates in cultured F-9 teratocarcinoma cells.
    Shen WC, Ballou B, Ryser HJ, Hakala TR.
    Cancer Res; 1986 Aug 15; 46(8):3912-6. PubMed ID: 2873883
    [Abstract] [Full Text] [Related]

  • 4. Potential therapeutic effect of adriamycin-monoclonal anti-prostatic acid phosphatase antibody conjugate on human prostate tumor.
    Deguchi T, Chu TM, Leong SS, Horozsewicz JS, Lee CL.
    J Urol; 1987 Feb 15; 137(2):353-8. PubMed ID: 3806841
    [Abstract] [Full Text] [Related]

  • 5. Intravenous injection of an immunoconjugate (anti-PSA-IgG conjugated to 5-fluoro-2'-deoxyuridine) selectively inhibits cell proliferation and induces cell death in human prostate cancer cell tumors grown in nude mice.
    Sinha AA, Quast BJ, Reddy PK, Elson MK, Wilson MJ.
    Anticancer Res; 1999 Feb 15; 19(2A):893-902. PubMed ID: 10368631
    [Abstract] [Full Text] [Related]

  • 6. Tumor and tissue distribution of a methotrexate-anti-EL4 immunoglobulin conjugate in EL4 lymphoma-bearing mice.
    Uadia P, Blair AH, Ghose T.
    Cancer Res; 1984 Oct 15; 44(10):4263-6. PubMed ID: 6467187
    [Abstract] [Full Text] [Related]

  • 7. Uptake of methotrexate linked to polyclonal and monoclonal antimelanoma antibodies by a human melanoma cell line.
    Uadia P, Blair AH, Ghose T, Ferrone S.
    J Natl Cancer Inst; 1985 Jan 15; 74(1):29-35. PubMed ID: 3855485
    [Abstract] [Full Text] [Related]

  • 8. Effect of conjugation on the biodistribution of 111In-labelled anti-PAP and anti-PSA monoclonal antibodies examined in nude mice with PC-82 human tumor xenografts.
    Perälä-Heape M, Vihko P, Pelkonen I, Laine A, Vihko R.
    In Vivo; 1991 Jan 15; 5(2):159-65. PubMed ID: 1722716
    [Abstract] [Full Text] [Related]

  • 9. Delivery of radionuclides to pretargeted monoclonal antibodies using dihydrofolate reductase and methotrexate in an affinity system.
    Hawkins GA, McCabe RP, Kim CH, Subramanian R, Bredehorst R, McCullers GA, Vogel CW, Hanna MG, Pomato N.
    Cancer Res; 1993 May 15; 53(10 Suppl):2368-73. PubMed ID: 8485723
    [Abstract] [Full Text] [Related]

  • 10. [Importance of the conjugated antibody for the induction of selective effect of adriamycin conjugated with anti AFP monoclonal antibody and entrapped in liposomes against AFP producing tumors].
    Konno H, Kumai K, Tsubouchi T, Ishibiki K, Abe O, Tadakuma T, Yasuda T, Nagaike K, Hosokawa S, Sakaguchi S.
    Gan To Kagaku Ryoho; 1989 Jun 15; 16(6):2213-7. PubMed ID: 2472119
    [Abstract] [Full Text] [Related]

  • 11. Antibody immunoglobulin G (IgG) against human prostatic specific antigen (PSA) as a carrier protein for chemotherapeutic drugs to human prostate tumors: Part 1. A double immunofluorescence analysis.
    Sinha AA, Sackrison JL, DeLeon OF, Wilson MJ, Gleason DF.
    Anat Rec; 1996 Aug 15; 245(4):652-61. PubMed ID: 8837723
    [Abstract] [Full Text] [Related]

  • 12. Immunocytochemical localization of an immunoconjugate (antibody IgG against prostatic acid phosphatase conjugated to 5-fluoro-2'-deoxyuridine) in human prostate tumors.
    Sinha AA, Quast BJ, Wilson MJ, Reddy PK, Fernandes ET, Ewing SL, Gleason DF.
    Anticancer Res; 1998 Aug 15; 18(3A):1385-92. PubMed ID: 9673345
    [Abstract] [Full Text] [Related]

  • 13. Specific tumour localisation of a huA33 antibody--carboxypeptidase A conjugate and activation of methotrexate-phenylalanine.
    Deckert PM, Bornmann WG, Ritter G, Williams C, Franke J, Keilholz U, Thiel E, Old LJ, Bertino JR, Welt S.
    Int J Oncol; 2004 May 15; 24(5):1289-95. PubMed ID: 15067353
    [Abstract] [Full Text] [Related]

  • 14. Site-specifically traced drug release and biodistribution of a paclitaxel-antibody conjugate toward improvement of the linker structure.
    Safavy A, Georg GI, Vander Velde D, Raisch KP, Safavy K, Carpenter M, Wang W, Bonner JA, Khazaeli MB, Buchsbaum DJ.
    Bioconjug Chem; 2004 May 15; 15(6):1264-74. PubMed ID: 15546192
    [Abstract] [Full Text] [Related]

  • 15. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
    Ramakrishnan S, Houston LL.
    Cancer Res; 1984 Apr 15; 44(4):1398-404. PubMed ID: 6142765
    [Abstract] [Full Text] [Related]

  • 16. Targeting of methotrexate-containing liposomes with a monoclonal antibody against human renal cancer.
    Singh M, Ghose T, Faulkner G, Kralovec J, Mezei M.
    Cancer Res; 1989 Jul 15; 49(14):3976-84. PubMed ID: 2660984
    [Abstract] [Full Text] [Related]

  • 17. The preparation, characterization and application of monoclonal antibodies to human prostatic acid phosphatase (PAP).
    Sturgeon CM, Micklem LR, Hussey AJ, Seth J, Scott A, Ritchie AW, Chisholm GD, James K.
    Dev Biol Stand; 1984 Jul 15; 57():331-40. PubMed ID: 6084620
    [Abstract] [Full Text] [Related]

  • 18. Preparation and characterization of methotrexate-immunoglobulin conjugates.
    Ghosh MK, Kildsig DO, Mitra AK.
    Drug Des Deliv; 1989 Jan 15; 4(1):13-25. PubMed ID: 2789065
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery.
    Safavy A, Bonner JA, Waksal HW, Buchsbaum DJ, Gillespie GY, Khazaeli MB, Arani R, Chen DT, Carpenter M, Raisch KP.
    Bioconjug Chem; 2003 Jan 15; 14(2):302-10. PubMed ID: 12643740
    [Abstract] [Full Text] [Related]

  • 20. [In vitro and in vivo antitumor activity of monoclonal anti-MM46 antibody-ricin A chain conjugate].
    Takahashi T, Seto M, Hara T.
    Gan To Kagaku Ryoho; 1983 Aug 15; 10(8):1894-1900. PubMed ID: 6882010
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.